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Homo- and Heterotypic Cell Contacts in Malignant
Melanoma Cells and Desmoglein 2 as a Novel Solitary
Surface Glycoprotein
Christian J. Schmitt1,2, Werner W. Franke2, Sergij Goerdt1, Berit Falkowska-Hansen3, Steffen Rickelt2 and
Wiebke K. Peitsch1,2
During progression of melanomas, a crucial role has been attributed to alterations of cell–cell adhesions,
specifically, to a ‘‘cadherin switch’’ from E- to N-cadherin (cad). We have examined the adhesion of melanoma
cells to each other and to keratinocytes. When different human melanoma cell lines were studied by protein
analysis and immunofluorescence microscopy, six of eight lines contained N-cad, three E-cad, and five P-cad,
and some lines had more than one cad. Surprisingly, two N-cad-positive lines, MeWo and C32, also contained
desmoglein 2 (Dsg2), a desmosomal cad previously not reported for melanomas, whereas other desmosome-
specific proteins were absent. This finding was confirmed by reverse transcriptase–PCR, immunoprecipitation,
and matrix-assisted laser desorption ionization–time of flight analyses. Double-label confocal and immunoelec-
tron microscopy showed N-cad, a- and b-catenin in plaque-bearing puncta adhaerentia, whereas Dsg2 was
distributed rather diffusely over the cell surface. In cocultures with HaCaT keratinocytes Dsg2 was found in
heterotypic cell contact regions. Correspondingly, immunohistochemistry revealed Dsg2 in five of 10 melanoma
metastases. Together, we show that melanoma cell adhesions are more heterogeneous than expected and that
certain cells devoid of desmosomes contain Dsg2 in a non-junction-restricted form. Future studies will have to
clarify the diagnostic and prognostic significance of these different adhesion protein subtypes.
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INTRODUCTION
Under physiological conditions, melanocytes and keratino-
cytes form the ‘‘epidermal melanin unit’’ of the epidermis.
Melanocytes are located in the basal layer, in a life-long
stable ratio of 1:5 with basal keratinocytes. Dysregulation of
this homeostasis may lead to uncontrolled proliferation of the
melanocytes and, ultimately, to the development of malig-
nant melanoma (MM). The exact molecular mechanism of
this dysregulation is unknown, but an important role has been
attributed to alterations in cell–cell communication and
adhesion. For example, it has been reported that, compared
with normal melanocytes, melanoma cells produce increased
amounts of cell adhesion receptors of the immunoglobulin
superfamily, correlated with enhanced tumorigenicity and
invasiveness (reviewed by Haass et al., 2005).
A group of special importance involved in development
and progression of tumors are the cadherins (cads), calcium-
dependent transmembrane glycoproteins mediating intercel-
lular adhesion, mostly by homophilic interactions (see the
reviews Duguay et al., 2003; Wheelock and Johnson, 2003).
So far, more than 80 members of the larger cad superfamily
have been identified, including the classical type I and type II
cads, which are components of adhering junctions, the
desmosomal cads (desmogleins (Dsgs) 1–4 and desmocollins
(Dscs) 1–3; for a recent review, see Getsios et al., 2004),
protocadherins, fats, seven-pass transmembrane cads, and
Ret tyrosine kinases. The type I cads comprise E-cad, typically
synthesized by epithelial cells, N-cad on neuronal and
mesenchymal cells, and P-cad, first identified in the placenta,
and differ from type II cads by the adhesive HAV domain (for
review see Nollet et al., 2000). Cads can mediate both
homotypic cell–cell interactions, that is, between cells of the
same type and heterotypic adhesions between two different
cell types.
In normal epidermis, heterotypic melanocyte–keratinocyte
adhesions are formed by E-cad (Tang et al., 1994). However,
during development of MM, E-cad often appears to be
downregulated and replaced by N-cad (Hsu et al., 1996).
This phenomenon, also known as ‘‘cadherin switch’’, seems
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important not only for the pathogenesis of MM, but also for
some tumrs of epithelial origin (see the reviews Christofori,
2003; Cavallaro and Christofori, 2004; Haass et al., 2004).
According to some authors (Li et al., 2001a), N-cad
can promote survival and migration of melanoma cells.
For melanoma cells, it has also been reported that re-
expression of E-cad might restore keratinocyte-mediated
growth control and reverse malignancy (Hsu et al., 2000;
Li et al., 2004).
In developmental biology, the differentiation and topogen-
esis of melanocytes provides remarkable examples of cell
migration over long distances as well as of drastic changes of
cell character, including pigmentation and cell–cell adhesion
(for a ‘‘classic’’ review, see Le Douarin, 1984). Thus, in
typical adhering junctions the originally dominant N-cad can
be accompanied and taken over by E-cad and this may then
be reversed during malignant growth (see, e.g., Tepass et al.,
2000; Niessen and Gumbiner, 2002; Duguay et al., 2003;
Foty and Steinberg, 2005).
According to a predominant working hypothesis in cancer
research, the switch from E- to N-cad has several functional
implications. First, it provides the melanoma cells with a new
adhesive repertoire to interact with new, mostly mesenchy-
mal neighbors such as fibroblasts (Li et al., 2001a), blood
vessels, and lymphatic tissues. Moreover, N-cad is also
thought to be responsible for the transendothelial migration
of melanoma cells (Sandig et al., 1997; Li et al., 2001a;
Qi et al., 2005). Second, the ‘‘cadherin switch’’ may provide
proliferative and pro-migratory signals (Kuphal et al., 2004;
Qi et al., 2005, 2006; Kuphal and Bosserhoff, 2006). As to
other mechanisms regulating E- and N-cad expression in
melanoma, several pathways and cell–cell cross-talk interac-
tions have recently been discussed (Poser et al., 2001; Qian
et al., 2004; Robert et al., 2006; Liu et al., 2006; see the
review Huber et al., 2005).
Functional implications of the ‘‘cadherin switch’’ on
melanoma development and progression have been de-
scribed by the Herlyn group and others, who mostly used
in vitro cell culture systems, including two- and three-
dimensional organotypic cultures as well as animal models
(Hsu et al., 2000; Li et al., 2001a; 2004; Liu et al., 2006).
Immunohistochemical examinations on MMs and their
metastases, however, have indicated that this concept in its
purest form cannot be conferred 100% to the situation in situ.
For example, a proportion of melanoma cells in metastases
are still positive for E-cad and negative for N-cad (Danen
et al., 1996; Hsu et al., 1996; Silye et al., 1998; Sanders et al.,
1999). This has led us to search for further cell adhesion
molecules involved, both in melanoma cell cultures, in two-
and three-dimensional melanoma–keratinocyte cocultures,
and in cryostat sections of melanoma metastases. We have
found that the cad repertoire of melanoma cells –even within
one cell – can be much more heterogeneous than expected.
Moreover, most surprisingly, we made the observation that
despite the absence of desmosomes and other desmosomal
constituents, a number of melanoma cell lines in culture as
well as a proportion of melanoma metastatic cells contain, in
addition to classical cads, noticeable amounts of the
desmosomal cad, Dsg2, as a widely spread, non-junction-
bound transmembrane cell–cell adhesion protein.
RESULTS
Coexistence of classical cads in certain melanoma cells
To elucidate the molecular composition of plaque-bearing
junctions in MM cells, we first performed immunocytochem-
istry on several cultured human melanoma cell lines, using
antibodies to classical cads. In general, cells were grown to
rather high density, as the confluency of cell cultures is
known to affect the expression pattern of cads. In WM35
cells, for example (Figure 1), we found more than 90% of the
cells to be intensely positive for N-cad, as expected (Figure
1b, c, e, and f). In addition, B30% of the cells contained
E-cad (Figure 1a, c, h, and i), thus confirming Smalley et al.
(2005) andB20% P-cad (Figure 1d, f, g, and i), both enriched
at intercellular contacts, like N-cad. As seen by double-label
confocal microscopy, these three classical cads often
appeared in mutually exclusive patterns, but occasionally
also within the same cell, showing at least partly overlapping
localization (Figure 1c, f, and i, asterisks). In some cells, we
could notice co-occurrence of all three cads. To examine our
results with a biochemical identification method, immuno-
blot analyses were performed, showing specific bands for N-,
E-, and P-cad in WM35 cells (Figure 1j, lane 5) as well as
coexistence of N- and P-cad in another melanoma cell line,
C32 (lane 4). In coimmunoprecipitation (IP) experiments,
conducted again with WM35 cell lysates, all three cads were
found to coimmunoprecipitate with the adhering junction
plaque protein b-catenin (cat) (Figure 1k, lanes 2–4). N- and
E-cad as well as N- and P-cad did not coprecipitate (lane 2).
Remarkably, however, P-cad was specifically enriched in
E-cad immunoprecipitates (lane 3), an observation made with
two different solubilization buffers (1% Triton X-100 buffer,
Figure 1k, and RIPA buffer; data not shown), suggestive of the
existence of heterotypic E- and P-cad complexes.
Detection and biochemical characterization of Dsg2 in specific
melanoma cell lines
Our findings on WM35 cells led us to a more detailed
analysis of melanoma cell junctions. To this end, immunoblot
analyses with diverse antibodies against proteins of adhering
junctions, desmosomes, and tight junctions were performed
on eight different human melanoma cell lines (Figure 2 and
Table 1). Six of these eight lines contained N-cad, three
WM35, SK-MEL-2, and Malme-3M, were positive for E-cad.
In addition, P-cad was detected in five of eight lines, among
those both N-cad- (WM-115, C32, and WM35) and E-cad-
positive ones (SK-MEL-2, Malme-3M, and WM35). Line WM-
115 also contained, in addition to N- and P-cad, cad 11, a
cad typical for mesenchymal stem cells (Simonneau et al.,
1995; Wuchter et al., 2007). Together, our analyses show that
cad complements of melanoma cells are more heterogeneous
than hitherto thought.
When the different melanoma cell lysates were immuno-
blotted with antibodies against desmosomal proteins
(Figure 2; for a survey see Table 1), we detected Dsg2, a
desmosomal cad normally synthesized in keratinocytes in the
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basal epidermal layer, in two of eight melanoma lines, MeWo
and C32, an unexpected finding confirmed with three
different Dsg2 mAbs (clones DG3.10, 6D8, and 10G11;
Figure 2). By contrast, all other desmosomal cads examined,
that is, Dsg1 and 3 and Dscs 1–3, were absent. With regard to
desmosomal plaque proteins, rather small amounts of
plakoglobin, known as a common constituent of both
desmosomal and adhering junction plaques (Cowin et al.,
1986), were detected in a number of melanoma cell lines,
including the Dsg2-positive line C32. Moreover, the
other Dsg2-positive line, MeWo, contained plakophilin
(PKP) 3 and another line, WM-115, was positive for PKP1,
2, and 3, but negative for desmosomal cads. Interestingly,
MeWo cells also synthesized another plaque protein,
neurojungin, an arm-repeat protein described previously
as a constituent of heterotypic adhering junctions specific
for the outer limiting zone of the retina (Paffenholz et al.,
1999).
Figure 1. Patterns of coexistence of different classical cads in cultured melanoma cells. (a–i) Double-label immunofluorescence confocal microscopy of
human WM35 melanoma cells using antibodies against N-cad (green in b, c, e and f), E-cad (red in a and c, green in h and i), and P-cad (red in d, f, g, and i),
showing that the vast majority of the cells contain N-cad, which appears enriched at intercellular contacts and along cell borders, but also that a minor
proportion of the cells is positive for E- and/or P-cad. The different classical cads can sometimes be found in the same cell (asterisks), but occasionally also in
mutually exclusive cell patterns (c, f, and i). Bars¼20 mm. (j) Immunoblot analysis of the SDS-PAGE-separated polypeptides of total cell lysates from human
HaCaT keratinocytes, SV80 fibroblasts, and different human melanoma lines (MeWo, C32 and WM35), confirming the coexistence of more than one
classical cad in a given cell line, that is, N- and P-cad in C32 cells and N-, E-, and P-cad in WM35 cells. Equal amounts of proteins have been loaded.
(k) Immunoblots of the SDS-PAGE-separated proteins of IPs from WM35 cell lysates, using N-, E-, and P-cad as well as b-cat antibodies. Note that N-cad
coprecipitates neither with E- nor P-cad, whereas P-cad is pulled down in E-cad immunoprecipitates. S, supernatant before IP; P, material after preclearing.
MW markers are indicated on the left margins.
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Analyses of tight junction proteins revealed proteins ZO-1
and -2 in all melanoma cell lines examined (Table 1; see also
Smalley et al., 2005). However, proteins ZO-1 and -2 can
occur both at adhering and at tight junctions (Itoh et al.,
1993, 1999) and indeed, it has been shown that in melanoma
cells, ZO-1 is associated with adhering junctions (Smalley
et al., 2005). All other tight junction proteins probed,
including the transmembrane constituents occludin and
claudins 1 and 4, were not detected.
Clearly, the most unexpected result was the detection of
Dsg2 in cells devoid of almost all other desmosomal
constituents. To substantiate further this finding, PCR analysis
was performed and the expected Dsg2 fragments were seen
in both MeWo and C32 cells (Figure 3a). As another group
had reported the detection of Dsg1 in different melanoma cell
lines (Li et al., 2001b), a finding contrasting with our own
immunoblot results, we also conducted PCR experiments
with Dsg1-specific primers. However, no amplification was
seen in the melanoma lines (Figure 3a).
To identify candidates for interaction with Dsg2, lysates
from lines C32 (Figure 3b) or MeWo (data not shown) were
subjected to IP, followed by SDS-PAGE and matrix-assisted
laser desorption ionization–time-of-flight analysis. In the
Dsg2 immunoprecipitates, a B160-kDa band appeared,
which was identified as Dsg2 (Figure 3b, lane 3), but no
other protein was specifically enriched. By contrast, in
control IPs with b-cat antibodies, a 130-kDa band, corres-
ponding to N-cad, and a 90 -kDa band representing a-cat
were coimmunopreciptated with b-cat (Figure 3b, lane 4),
that is, known functional protein complexes of adhering
junctions. Essentially the same IP results were obtained in
MeWo cells.
Subcellular localization of Dsg2 in melanoma lines
When we determined the subcellular distribution of Dsg2 by
confocal microscopy, Dsg2 enrichment was observed at sites
of cell–cell contacts, but also along free plasma membrane
boundaries (Figure 4d and f). The classic plaque protein,
b-cat, examined for comparison and control, was also
accumulated at intercellular junctions, but appeared weaker
at free cell borders (Figure 4b, c, e, and f) and did not
codistribute with Dsg2 (Figure 4f). On the contrary, double
labelling for b-cat and N-cad gave near-complete colocaliza-
tion (Figure 4a–c) and the same applied for the comparison of
a-cat and protein p120ctn (data not shown). When MeWo
cells were labelled for PKP3 and neurojungin and C32 cells
for plakoglobin, all three proteins were diffusely distributed,
without any specific enrichment at a distinct structure, and
this was observed with different fixation and staining
protocols (data not shown; see Materials and Methods). Co-
IPs in MeWo cells did not reveal interactions of Dsg2 with
PKP3 or b-cat (Figure 4g). When C32 cell lysates were
immunoprecipitated with Dsg2 antibodies, minor amounts of
plakoglobin were pulled down and a weak plakoglobin band
also appeared in b-cat immunoprecipitates (data not shown).
Yet, similar as in MeWo cells, Dsg2 and b-cat did not
coimmunoprecipitate. Moreover, like in WM35 cells, no
co-IP of N- with P-cad was observed (data not shown).
-cat
Plakoglobin
Neurojungin
Figure 2. Immunoblot detection of adhering junction-associated and
desmosomal proteins in different cultured human melanoma cell lines.
Equal amounts of total proteins from seven human melanoma lines (MeWo,
WM-115, WM-266–4, WM-793, C32, Sk-Mel-2, and Malme-3M) as well as
from HaCaT keratinocytes and SV80 fibroblasts, loaded for comparison, were
probed with antibodies against classical cads (N-, E-, and P-cad and cad 11),
arm-type plaque proteins of adhering junctions (b-cat, protein p120ctn,
plakoglobin, and neurojungin), desmosomal cads (Dsg1–3 and Dsc1–3), and
desmosomal plaque proteins (desmoplakin and PKP1–3). Five of the seven
melanoma cell lines contain N-cad, two possess E-cad, four show P-cad
and cad 11 is only found in one line. Interestingly, two melanoma lines,
MeWo and C32, synthesize the desmosomal cad Dsg2, in the absence of all
other desmosomal cads, a finding confirmed by immunoblotting with three
different Dsg2 mAbs (clones DG3.10, 6D8, and 10G11). PKP1–3 are found in
WM-115 cells and PKP3 occurs as the single PKP in MeWo cells, which,
surprisingly, also contain the neuronal-type component of special kinds of
adhering junctions (cf. Paffenholz et al., 1999). *For immunoblot detection
of Dsg1, whole cell lysates of human epidermis were loaded as positive
control instead of HaCaT cell lysates.
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To clarify the molecular complement of melanoma cell
junctions and, in particular, the localization of Dsg2, we
performed electron and immunoelectron microscopy of
MeWo cells (Figure 5). Ultrathin sections revealed small
plaque-bearing adhering junctions of the puncta adhaerentia
category (Figure 5a–c; arrows) the plaques of which showed
associations with actin microfilaments as well as lateral
neighborhood to intermediate-sized filaments (Figure 5b and
c). In molecular terms, these puncta junctions were identified
by their cat and p120ctn components, and immunoelectron
microscopy in general showed marked and specific enrich-
ment in their plaques (Figure 5d–f; arrowheads). In addition,
minor b-cat reactions could also be detected in junction-free
plasma membrane regions (Figure 5d and e; arrows). Dsg2
Table 1. Detection of proteins associated with adhering junctions, desmosomes, and tight junctions in different
melanoma cell culture lines
MeWo WM-115 WM-226-4 WM-793 C32 SK-Mel-2 Malme-3M WM35
Adhering junction proteins
N-cadherin + + + + +   +
E-cadherin      + + +
P-cadherin  +   + + + +
VE-cadherin        
Cadherin 11  +      
Cadherin 6        
a-catenin + + + + + + + +
b-catenin + + + + + + + +
p120ctn + + + + + + + +
Vinculin + + + + + + + +
a-Actinin + + + + + + + +
Plakoglobin1 (+) (+) + + + + + +
ZO-12 + + + + + + + +
ZO-22 + + + + + + + +
Drebrin3 + + + + + + + +
Neurojungin +       
Desmosomal proteins
Desmoglein 1        
Desmoglein 2 +    +   
Desmoglein 3        
Desmocollin 1        
Desmocollin 2        
Desmocollin 3        
Plakophilin 1  +      
Plakophilin 2  +      
Plakophilin 3 + +  +    
Desmoplakin 1        
Desmoplakin 2        
Plakoglobin1 (+) (+) + + + + + +
Tight junction proteins
ZO-12 + + + + + + + +
ZO-22 + + + + + + + +
Occludin        
Claudin 1        
Claudin 4        
1Plaque component of both adhering junctions and desmosomes.
2Proteins occurring both at adhering and at tight junctions.
3For references with respect to adhering junction localization, see Peitsch et al. (1999, 2005).
(+) Trace amounts detectable by immunoblot analysis.
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was seen along the entire cell surface, but without any
specific enhancements at plaques (Figure 5g).
Distribution of adhering junction proteins and Dsg2 in
coculture systems
To assess the possible role of Dsg2 and the adhering junction
proteins in heterotypic cell–cell adhesions of melanoma cells,
coculture systems confronting melanoma cells with fibro-
blasts or keratinocytes of line HaCaT were established. When
two-dimensional MeWo cell-fibroblast cocultures were
reacted with antibodies to adhering junction proteins,
including N-cad, a- and b-cat, and protein p120ctn, they all
labelled homotypic fibroblast and homotypic melanoma
junctions as well as heterotypic melanoma–fibroblast junc-
tions. As an example, the reaction of N-cad is shown in
Figure 6a. Dsg2 staining of such cocultures revealed absence
of this protein from fibroblasts, as expected, but demonstrated
enrichment at the homotypic cell borders of MeWo cells
(Figure 6c). In cocultures of C32 (Figure 6e–j) or MeWo
cells with HaCaT keratinocytes, E-cad and desmosomal
cads, except Dsg2, appeared exclusively in the keratinocytes:
E-cad in linear arrays representing the series of adhering
junctions (Figure 6e and f), the desmosomal proteins in
their typical punctate arrays (data not shown). In contrast,
reaction sites of b-cat (Figure 6g and h) as well as of a-cat,
and protein p120ctn (data not shown) were accumulated
both along homotypic adhering junctions of melanoma and
HaCaT cells and in regions indicative of heterotypic contacts.
Correspondingly, Dsg2 was seen at the heterotypic
interaction borders between melanoma and HaCaT cells
(Figure 6i and j).
As a cell culture model of the situation in vivo organotypic
cultures of MeWo or C32 cells with HaCaT keratinocytes
were prepared. Keratinocytes and melanoma cells were
mixed in a 5:1 ratio, corresponding to the physiological ratio
in the basal epidermal layer and these cultures were exposed
to an air–liquid interface for two weeks to allow differentia-
tion of the keratinocytes and formation of a stratified
epidermal equivalent (Figure 7). In MeWo–HaCaT organo-
typic cocultures, MeWo cells, a line originally generated
from a melanoma lypmph node metastasis (cf. Table 3),
formed cell clusters in subepidermal nests (Figure 7a–f).
Immunostainings for b-cat (Figure 7a and b) and other
adhering junction plaque proteins (data not shown) were
positive not only at homotypic junctions between the
keratinocytes on the one hand and MeWo cells on the other,
but also at contact sites between the basal keratinocytes and
the subepidermally located melanoma cells (Figure 7b). Dsg2
was detected in remarkable intensity at the MeWo cell
contacts as well as in the basal layer of the epidermal
equivalent, corresponding to the situation in vivo and at the
boundaries between MeWo cells and basal keratinocytes
(Figure 7e and f). By contrast, the reactions for Dsg 1 were
rather inverse, showing strongly positive reactions in the
upper epidermal layers. Clearly, this protein was absent from
the melanoma cells (Figure 7c and d; cf. Figure 7i and j).
Different from the MeWo cells, cells of the line C32
originated from a primary amelanotic melanoma, did not
invade the epidermal equivalent but formed a compact
multilayer tumor on top of it (Figure 7g–l). Otherwise, the
distribution pattern of the adhering junction-associated and
desmosomal proteins was similar to that noted in the
MeWo–HaCaT organotypic cocultures.
Cad patterns in melanoma metastases in situ
To verify whether our results with cell culture systems might
also be relevant for genuine tumors in situ, small samples of
melanoma metastases from 10 different patients, originating
from skin, lymph node, or lung tissue, all positive for melan-
A, were analyzed by immunofluorescence microscopy
(Figure 8 and Table 2). Eight of 10 metastases contained
N-cad, enriched along cell boundaries (Figure 8a, c, d, f, j,
and l) and in seven of the 10 metastases, at least a
subpopulation of the tumor cells was positive for E-cad
(cf. Figure 8e, f, n, and o and Table 2). Coexistence of both
classical cads was noted in six metastases and double-label
confocal microscopy revealed that they could occur both
separately in different cell clusters and together within the
same cell (Figure 8f). P- and VE-cad were detected each
in two of 10 metastases, but only in small cell groups,
representing less than 20% of the tumor cells (Table 2).
Interestingly, two metastases contained some cells positive
-
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t I
P
Control
a b
Figure 3. Specific detection of Dsg2 in MeWo and C32 cells at the mRNA
level and by matrix-assisted laser desorption ionization–time of flight
analysis. (a) PCR analysis of MeWo, C32, and WM35 melanoma cells using
primers specific for the Dsg1 and 2 as well as for the actin-binding protein
drebrin. Dsg2 is detected in MeWo and C32 melanoma cells, whereas none
of the melanoma lines analyzed contains Dsg1. Human split skin has been
employed as positive control for the Dsg1 PCR, HaCaT keratinocytes for
the Dsg2 PCR, and SV80 cells as negative control. Size markers: 396 and
356 bp (Dsg1 and Dsg2 PCR) or 356 and 247 bp (drebrin PCR). (b) Coomassie
blue-stained 4–20% acrylamide gel, showing proteins immunopreciptated
from C32 cell lysates with antibodies to Dsg2 or b-cat. In the Dsg2
immunoprecipitate, a solitary band of B160 kDa is seen, which has been
identified as Dsg2 by matrix-assisted laser desorption ionization–time of
flight analysis. In the b-cat immunoprecipitate, a band at B130 kDa
represents N-cad, and bands at 90–100 kDa contain a- and b-cat. Further
bands at 66, 55, and B30 kDa correspond to bovine serum albumin and the
heavy and light Ig chains of the antibodies. P, material of the preclearing step;
M, molecular weight marker, as indicated on the left margin.
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for Dsg1, which at least, in one of these, appeared enhanced
at cell boundaries (Table 2). Moreover, and most remarkably,
Dsg2 was found in five of the 10 metastases and in four
of them, even more than 50% of the tumor cells were positive
(Table 2 and Figure 8g–o). As to subcellular distribution,
significant cell border enrichment was noted in three of the
five Dsg2-positive metastases (cf. Figure 8g, i, j, m, l, o),
whereas the other two showed diffuse cytoplasmic staining
(data not shown). When the Dsg2-positive metastases were
double-labelled with antibodies to N- (Figure 8j–l) or E-cad
(Figure 8m–o), it was evident that Dsg2 could occur both in
N- and E-cad-containing cells (Figure 8l and o), apparently
independent of the two classical cad pattern.
Surprisingly, in one metastasis, no. 864, which in its
histology did not markedly differ from the other metastases,
neither N-, E-, VE-, nor P-cad and cad 11 immunostaining
was significant along cell–cell boundaries. However, most
cell borders were labelled by antibodies against a- and b-cat
and protein p120ctn. Moreover, a variable number of tumor
cells were positive for Dsg1, 2, and 3, all appearing
accumulated along cell boundaries, whereas desmosome-
specific plaque proteins were not detected by immunofluore-
scence microscopy. Therefore, we decided to extend our
research on this specific subtype to a greater number of
tumors.
Together, our observations in situ indicated that the cad
patterns and combinations were more variable than anti-
cipated and that metastases could comprise extremely
heterogeneous subcompartments, reflecting our observations
in vitro.
DISCUSSION
Our study has given three important results: first, the cad
pattern of melanomas can be quite heterogeneous and certain
melanoma cell lines as well as metastases can synthesize
several – up to three – classical cads within the same cell.
Second, a proportion of cultured melanoma cells and
melanoma metastases contain, in addition, the desmosomal
cad Dsg2, which, in the absence of desmosomes, is dispersed
over the cell surface. Third, this complex cad complement
contributes to the remarkable diversity of options of
melanoma cells to form heterotypic cell–cell interactions.
Thus, the facultative cad repertoire of melanoma cells might
be much larger than previously thought, probably depending
not only on the degree of malignancy but also on the specific
growth conditions and the microenvironment.
Figure 4. Differential distribution of Dsg2, compared with adhering junction proteins, in cultured melanoma cells. (a–f) Confocal microscopy of MeWo
melanoma cells, stained for b-cat (green in b, c, e, and f) in combination with N-cad (red in a and c) or with Dsg2 (red in d and f). All three proteins are enriched
at intercellular junctions and along free cell boundaries. Although b-cat and N-cad show (c) far-reaching colocalization , (f) localizations of b-cat and Dsg2 are
completely distinct. Bar¼ 20mm. (g) IP and immunoblot analysis of MeWo cell lysates with antibodies to Dsg2, PKP3, and b-cat, showing no co-IP, indicating
that in the specific lysate they occur in different protein complexes.
www.jidonline.org 2197
CJ Schmitt et al.
Desmoglein 2 in Melanoma cells
Heterogeneous cad profiles and their implications
It is well known that under certain circumstances, melanoma
cells can synthesize other cads than N- or E-cad. For
example, P-cad has been identified in melanoma cells (Hsu
et al., 1996; Bauer et al., 2005, 2006) and has been reported,
similar to E-cad, to promote cell–cell adhesion and counter-
act invasion (Van Marck et al., 2005). Moreover, the amount
of P-cad appears to have a prognostic relevance, as a loss of
P-cad is commonly seen in advanced melanomas and
melanoma metastases (Bauer et al., 2006). This seems in
accordance with our findings on melanoma metastases in
which only a very small subpopulation of cells was P-cad-
positive. In addition to P-cad, melanoma cells may faculta-
tively also synthesize VE-cad, a cad characteristic for
endothelial cells, that has been related to highly aggressive
melanoma cell lines undergoing ‘‘vasculogenic mimicry’’, a
process facilitating hematogeneous metastasis (Hendrix et al.,
2001; Hess et al., 2006). Our melanoma lines were all VE-
cad-negative, but two of 10 metastases comprised small
subgroups of VE-cad-positive cells.
Surprisingly, one of eight melanoma cell culture lines
examined in our study contained cad 11, a type II classical
cad originally identified in osteoblasts but later also detected
in diverse other cells of mesenchymal origin which had so far
not been described in melanoma cells. In an earlier study, six
novel, yet not further characterized cad fragments, termed
ME1–ME6, have been identified in melanoma cell lines by
PCR (Matsuyoshi et al., 1997).
Heterogeneity of subpopulations of melanoma cells might
also have important implications for the growth and spreading
of these tumors in situ. Although E-cad is known to inhibit and
N-cad to enhance proliferation, migration, and metastasis,
different immunohistochemical investigations have shown that
a proportion of melanoma metastases still contains significant
E-cad amounts (Danen et al., 1996; Silye et al., 1998; Sanders
et al., 1999; Andersen et al., 2004). In our study, one of 10
metastases contained E-cad as the only classical cad and six of
10 synthesized both E- and N-cad, occasionally in different
subcompartments of the tumor but sometimes even within the
same cell. Therefore, loss of E-cad is apparently not a universal
or an inevitable feature of tumor metastasis. Alternatively, it
could also be possible that in some melanomas, E-cad is only
temporarily downregulated during tumor development, but re-
expressed later in metastases. Remarkably, and in contrast to
other melanoma subtypes, it has been reported for uveal
melanoma that E-cad-containing tumors show an increased risk
for metastasis (Onken et al., 2006).
Our biochemical analyses in a melanoma cell line
containing E-, N-, and P-cad together, have shown that all
three cads form complexes with the same set of plaque
proteins of adhering junctions, that is, a- and b-cat,
plakoglobin, and protein p120ctn. Yet, although E- and N-
as well as P- and N-cad occur in different complexes, E- and
P-cad have been found to coimmunoprecipitate. Tradition-
ally, the cell–cell binding specificities of cads have been
considered as primarily homotypic. However, more recent
studies have shown that their interactions can also be more
promiscuous (e.g., Shimoyama et al., 2000; Niessen and
Gumbiner, 2002; see the review Patel et al., 2003). Results of
studies in cocultures of lens and liver cells (Volk et al., 1987)
or of epithelial cells and fibroblasts (Omelchenko et al.,
2001) have been taken as indications of heterotypic
a
b
c
d
e f
g
Figure 5. Electron and immunoelectron microscopy presenting cell–cell
contacts of MeWo cells. (a–c) Conventional electron microscopy. In (a) the
survey as well as in (b and c) more detailed, high-resolution micrographs,
several small, plaque-bearing puncta adhaerentia junctions are seen (arrows
in a–c; inset in a: higher magnification of such a junction). Note that at some
sites devoid of plaques, the plasma membranes of neighboring cells are
extremely close spaced, indicative of another form of junction (c).
L, lysosome. Bar¼ 700 nm. (d–g) Immunoelectron microscopy, using (d–f)
mAbs to b-cat and (g) to Dsg2 in combination with gold-coupled secondary
antibodies and signal enhancement by the silver technique. b-cat is densely
accumulated in the plaques of the puncta adhaerentia (arrowheads in d and e;
higher magnification in f). Moreover, plaque protein reactions are
sometimes also detected at plaque material of free plasma membranes (arrows
in d and e). Dsg2 staining is observed diffusely along the plasma membrane,
both at intercellular contact regions and along free cell membranes, with
occasional weak reactions at plaques (arrow) but, in contrast to b-cat, does
not show specific enrichment at these sites (g). Bar¼700 nm.
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adhesions formed by N- and E-cad. Moreover, L-cells
transfected with E- or P-cad are capable of forming
‘‘E–P heterocadherin’’ adhesions between adjacent cells
(Duguay et al., 2003; Foty and Steinberg, 2005). On the
other hand, it is now clear that certain cads may form lateral
cis-heterodimers (e.g., Shan et al., 2000) and specifically
E- and P-cad cis-heterodimers have been identified in A431
carcinoma cells (Klingelho¨fer et al., 2000). As to the
heterotypic E-P-cad complexes found in our study, their
cis- or trans-nature remains to be determined.
Dsg2 as a novel solitary cell surface component characteristic
of a subset of melanoma cells
A totally unexpected result of our study is that certain kinds of
melanoma cells synthesize the desmosomal cad Dsg2,
known as a widespread transmembrane glycoprotein of
desmosomes of all proliferative epithelial cells, keratinocytes
included (Scha¨fer et al., 1994). Via its intracellular domain,
Dsg2 interacts with plakoglobin which, in turn, can bind
other desmosomal plaque proteins, the PKPs and desmopla-
kin, the latter constituting a linker to intermediate filaments
(Troyanovsky et al., 1993; Chitaev et al., 1996; see the review
Getsios et al., 2004). In addition, Dsg2 is also an important
constituent of the area composita complex connecting
cardiomyocytes (Borrmann et al., 2006; Franke et al., 2006).
In our two melanoma cell lines, the Dsg2 distribution was
radically different from that known from all other cell types.
Here, the adhesive glycoprotein was spread over the cell
surface, with occasional clusters at otherwise inconspicuous
cell–cell contact sites. Biochemically, it was not found in
N-cad+S100
a e f
c d g h
i j
b
Dsg2+S100
Dsg2+S100 Dsg2
E-cad+S100 E-cad
-cat+melan-A -cat
Figure 6. Localization of adhering junction proteins and Dsg2 in adherent cell cocultures. (a–d) Confocal microscopy of cocultures of primary human
fibroblasts and MeWo melanoma cells, labelled for N-cad (red in a) or Dsg2 (red in c) in combination with S100 protein as melanoma marker (a and c; green).
(a) N-cad is detected both in homotypic melanoma–melanoma and fibroblast–fibroblast junctions and in regions of heterotypic contacts between the two
cell types, whereas Dsg2 staining is only seen on the surfaces of the S100-positive melanoma cells, here at intercellular contacts as well as along free cell
membranes (b and d, phase contrast images). Bar¼ 20mm. (e–j) Cocultures of HaCaT keratinocytes and C32 melanoma cells, immunostained for (e and f; red)
E-cad, (g and h; red) b-cat, (i and j; red) Dsg2, and the melanoma cell markers, (e and i; green) S100 and (green in g) melan-A. (e and f) Here, E-cad is
exclusively found along keratinocyte cell–cell borders containing adhering junctions. (g and h) By contrast, homotypic melanoma, homotypic keratinocyte,
and heterotypic melanoma–keratinocyte contact sites are strongly positive for b-cat. (i and j) The same holds for Dsg2, which in HaCaT cells appears in the
punctate pattern typical of demosomes. Bar¼20 mm.
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complexes with any other junctional proteins. A similar cell
surface distribution of Dsg2 was observed in the human
fibrosarcoma cell line HT-1080, the only cell line reported so
far to contain endogenous Dsg2 but no other desmosomal
constituents (Chitaev and Troyanovsky, 1997). When this cell
line was stepwise transfected with other desmosomal cads,
junction protein complexes were formed. It was even
possible to induce the formation of desmosomes by
cotransfection of the other desmosomal proteins, of which
the plaque protein, PKP2, played an especially important
anchoring role (Koeser et al., 2003).
When we systematically examined our Dsg2-positive
melanoma cell lines for other desmosomal proteins, we only
found plakoglobin, a constituent of both desmosomes and
adhering junctions, which was synthesized in C32 cells in
minor amounts and only in traces in MeWo cells. In addition,
in MeWo but not in C32 cells, PKP3 was detected, another
member of the p120ctn family of armadillo-related proteins
(see the review Schmidt and Ja¨ger, 2005). However, as seen
by immunolocalization, both plakoglobin and PKP3 occurred
predominantly in the cytoplasm and only small amounts of
plakoglobin coimmunoprecipitated with Dsg2 in C32 cells.
Thus, so far, Dsg2 appears as a primarily solitary cell surface
component. This raises the question whether it can in fact as
a single molecule type exert significant adhesive strength.
When L-cells, a mouse fibroblast line, were transfected with
cDNAs encoding single desmosomal cads or related chimeric
proteins in the absence of other desmosomal components,
the adhesive properties of the transfectants were only very
weak (Amagai et al., 1994; Chidgey et al., 1996; Kowalczyk
et al., 1996). However, in contrast to our melanoma cell
lines, these transfected L-cells were said to be devoid of any
functional adhering junctions and thus may lack initiating
components for desmosome formation (see the review
Getsios et al., 2004).
Another group has reported the synthesis of Dsg1 in
several melanoma cell lines and its downregulation by
autocrine hepatocyte growth factor, in parallel with down-
regulation of E-cad (Li et al., 2001b). In all the melanoma cell
lines we analyzed, including line WM35 used by Li et al.
(2001b), we did not detect Dsg1, neither at protein nor at the
mRNA level. On the other hand, our observation that the
Dsg1 antibody also used by Li et al. (clone 62, from BD
Biosciences Pharmingen; Heidelberg, Germany), not only
reacted with a 160-kDa band present in all melanoma cell
lines but also in fibroblasts used as negative control as well as
our matrix-assisted laser desorption ionization results that the
160-kDa component immunoprecipicated with this antibody
was identified as epidermal growth factor receptor (data not
shown) led us to the conclusion that this represents, most
probably, a cross-reaction of this antibody between the two
proteins.
-cat 
+ 
vim
Dsg2 
+ 
vim
Dsg1 
+ 
vim
a b
c d
e f
g h
i j
k l
HaCaT-MeWo organotypic cultures HaCaT-C32 organotypic cultures
-cat 
+ 
vim
Dsg2
+ 
vim
Dsg1
+ 
vim
Figure 7. Immunolocalizations of junctional proteins in organotypic keratinocyte-melanoma cell cocultures. Vimentin (green in a–k) has been generally used
as marker protein for the identification of melanoma cells. (a–f) In organotypic cultures of HaCaT keratinocytes with melanoma cells of line MeWo, the
keratinocytes form a stratified and differentiated epidermis with a stratum corneum equivalent layer on top, whereas cells of line MeWo, derived from a lymph
node metastasis, are densely aggregated in subepidermal cell clusters. As seen by double-label confocal microscopy, b-cat antibodies (a and b; red) mark
homotypic junctions, both between keratinocytes and between melanoma cells as well as regions of heterotypic contacts between the HaCaT and the
MeWo cells. Dsg1-positive reactions (c and d; red) are exclusively observed in the epidermis and here mostly in the upper layers. Clearly, the MeWo cells
appear Dsg1-negative. By contrast, Dsg2 (e and f; red) is enriched in the basal epidermal layer. Moreover, strong Dsg2 immunoreactions are noted at junctions
between the subepidermal MeWo cells as well as in areas of heterotypic MeWo cell–keratinocyte contacts. Bar¼20 mm. (g–l) In organotypic cocultures
confronting HaCaT keratinocytes with C32 cells, originated from a primary melanoma, the melanoma cells do not invade the epidermal equivalent but form
a dense multilayer conglomerate on top of it. Double-label confocal microscopy, using (g and h; red) antibodies to b-cat, (i and j; red) Dsg1, and (k and l; red)
Dsg2, in combination with (g–k; green) vimentin as a melanoma cell marker, reveals distribution patterns for b-cat and the desmosomal cads Dsg1 and 2 that
are similar to those in the organotypic HaCaT-MeWo cell cocultures. Bar¼20 mm.
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We have identified Dsg2 not only in monocultures of
melanoma cells but also in two- or three-dimensional
cocultures and in regions of both homotypic melanoma cell
and heterotypic melanoma–keratinocyte contacts. This im-
plies the possibility that Dsg2 can indeed act as a heterotypic
cell–cell adhesion molecule between keratinocytes and
melanoma cells. It will therefore be mandatory to investigate
the ultrastructural basis of such heterotypic contacts, espe-
cially as keratinocytes contain desmosomes and melanoma
cells do not. Moreover, it will be important to characterize
the subgroup of Dsg2-positive melanoma cells in greater
detail and its impact on melanoma progression and
metastasis. In this context, it may be remarkable that in our
organotypic cocultures, one of the Dsg2-positive lines, C32,
originated from a primary amelanotic melanoma, did not
invade into the artificial epidermis, whereas the other line,
MeWo, derived from a lymph node metastasis, formed
subepidermal melanoma cell nests as well as Dsg2-positive
contact sites with the basal keratinocytes.
Furthermore, it will be interesting to investigate normal
melanocytes for Dsg2. Indeed, our studies on normal human
epidermal melanocytes, both from newborn foreskin (NHEM-
f1, PromoCell, Heidelberg, Germany) and from adult skin
(NHEM-a1, PromoCell), cultured in serum-free medium, have
shown some amounts of Dsg2, both on RNA and on protein
level (unpublished results).
Together, our data indicate that a non-desmosome-
integrated, ‘‘free’’ cell surface glycoprotein Dsg2 might
represent a novel, primitive cell–cell adhesion system
characteristic of a certain subset of melanomas. We propose
to differentiate this subtype of melanoma cells in pathological
diagnosis and to characterize it in detail with respect to
interaction partners and regulatory proteins involved as well
as with respect to its adhesive strength and pathophysiolo-
gical implications, notably the tumor behavior of the Dsg2-
positive melanomas.
MATERIALS AND METHODS
Antibodies
Murine mAbs against N-, E-, and P-cad (clone 56), Dsg1 (clone 62),
a- and b-cat, and protein p120ctn were purchased from BD
Biosciences Pharmingen, whereas mAbs against vinculin (clone
11–5) and a-actinin (clone BM-75.2) as well as rabbit antisera to a- or
b-cat were obtained from Sigma (Deisenhofen, Germany). A rabbit
antiserum to N-cad was from QED Bioscience Inc. (San Diego, CA)
and a rabbit mAb to E-cad from Epitomics (obtained through Biomol
GmbH, Hamburg, Germany). Other mAbs, directed against cad 11,
P-cad (clone NCC-CAD-299), Dsg1 and 2 (clones 27B2 and 6D8),
and claudin 4 were obtained from Invitrogen (Karlsruhe, Germany),
as were polyclonal rabbit antibodies against proteins ZO-1 and -2,
occludin, and claudin 1. A cad 6 mAb was from USBiological
(obtained through Acris, Hiddenhausen, Germany) and a pan-Dsc
rabbit antiserum (clone AHP 322) from Serotec (Du¨sseldorf,
Germany). A mAb directed against cad 5 (VE-cad; clone BV9) was
kindly provided by Professor Elisabetta Dejana (Department of
Biomolecular and Biotechnological Sciences, School of Sciences,
University of Milan, Italy; cf. Lampugnani et al., 1992). The
neurojungin mAb was from Dr Rainer Paffenholz (Ingenium
Table 2. Classical and desmosomal cadherins in melanoma metastases in the lung, LN, or skin
Case no. MM 770 MM 761 MM 782 MM 841 MM 864 MM 906 MM 941 MM 944 MM 948 MM 962
Primary
melanoma MUP
SSM, back,
1.03 mm,
Clark level
III
NM,
shoulder,
1.5 mm,
Clark level
IV
NM, back,
4.5 mm
NM, chest,
1.0 mm,
Clark level
IV
SSM, chest,
1.9 mm,
Clark level
IV
Type
unknown,
shoulder,
3 mm
NM, knee,
4.0 mm,
Clark level
IV
NM, upper
arm,
4.0 mm,
Clark level
III
Peduncu-
lated,
ulcerated
melanoma
shoulder,
2.6 mm
Metastatic
site Lung
LN, supra-
clavicular LN, groin LN, axilla Lung Skin, axilla LN, groin LN, groin
Skin,
shoulder
Skin,
abdomen
Cadherin pattern in metastases
Classical cads
N-cad + +++ +++ ++  +++  +++ +++ +++
E-cad +++  ++ +   ++ +++ +++ +++
P-cad       +   +
VE-cad +  +       
Desmosomal cads
Dsg1 +    +++     
Dsg2 + +++ ++  ++     +++
LN, lymph node; MUP, melanoma of unknown primary; NM, nodular melanoma; SSM, superficial spreading melanoma.
Metastases withX10% buto50% immunoreactive tumor cells were classified as ‘‘+’’, those with 50–75% reactive cells as ‘‘++’’, and those withX75% as
‘‘+++’’.
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Pharmaceuticals AG, Martinsried, Germany; cf. Paffenholz et al.,
1999) and for the demonstration of plakoglobin, a mAb (clone 11E4)
from Professor Margaret J. Wheelock (University of Nebraska Medical
Center, Omaha, NE) was used. Rabbit antibodies against Dsg2 (clone
rb5) were a gift from Dr Lutz Langbein, guinea-pig antibodies against
vimentin (clone GP1) from PD Dr. Ilse Hofmann (both Division
of Cell Biology, German Cancer Research Center, Heidelberg,
Germany). The following antibodies against desmosomal and other
cytoskeletal proteins, most of which were generated in the Division
of Cell Biology of the German Cancer Research Center, were
purchased from Progen Biotechnik (Heidelberg, Germany): mAbs
against desmoplakins 1 and 2 (clones DP-2.15, -2.17, and -2.20;
Moll et al., 1986), plakoglobin (clone PG 5.1; Cowin et al., 1986),
PKP1, 2, and 3 (clones PP1–2D6, PP2/86, and PKP3–270.6.2,
respectively; Heid et al., 1994; Mertens et al., 1996; Schmidt et al.,
1999), Dsc1 and 3 (clones Dsc1-U100 and Dcs3-U114; Nuber et al.,
1996); Dsg1 (clone Dsg1-P23; Kurzen et al., 1998), Dsg1 and 2
(clone DG 3.10; Schmelz et al., 1986), Dsg2 (clone 10G11; Scha¨fer
et al., 1994), Dsg3 (clone Dsg-G194; Kurzen et al., 1998), vimentin
(clone VIM 3B4), and drebrin (clone MX823; Peitsch et al., 2005). As
melanoma markers, a mAb against melan-A and a rabbit antiserum
against S100 protein (both from Progen Biotechnik) were used.
Figure 8. Double-label confocal microscopy presenting heterogeneous cad patterns in melanoma metastases. Cryostat sections of metastasis no. 962
(exemplatory shown) have been labelled with antibodies to N-cad (Red in a, c, d, and f; green in k and l), E-cad (e, f, n, and o; green), and Dsg2 (red in d–m and
h–o) as well as with the melanoma cell marker melan-A (b, c, h, and i; green). In the metastasis presented, the vast majority of the melanoma cells exhibit
strongly positive N-cad staining at cell–cell junctions (a and c; red). A major subset of the tumor cells also contains (e and f, green) E-cad, often appearing in
the same cells as (f) N-cad. Moreover, large cell clusters also synthesize the desmosomal cad (g, j, m; i, l, o, red) Dsg2, which is markedly enriched along
the cell borders. This protein can occur in melanoma cells containing (l) N-cad as well as in those positive (o) for E-cad, thus appearing independent of the
classical cad profile. Bar¼ 20mm.
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For immunofluorescence microscopy, primary antibody com-
plexes were visualized with secondary antibodies coupled to Cy3
(Dianova, Hamburg, Germany) or Alexa 488 (MoBiTec, Go¨ttingen,
Germany). For immunoblot analysis, horseradish peroxidase-
conjugated secondary antibodies were applied in combination with
the enhanced chemiluminescence system (NEN, Ko¨ln, Germany).
Cell culture
Human melanoma cells of lines MeWo, WM-115, WM-266–4, WM-
793, C32, SK-Mel-2, Malme-3M, and WM35 as well as Simian virus
(SV40)-transformed human SV80 fibroblasts and human U333
glioma cells were provided by American Type Culture Collection
(Manassas, VA; for origins of the different melanoma lines, see
Table 3). HaCaT keratinocytes were obtained from Professor Petra
Boukamp (Genetics of Skin Carcinogenesis, German Cancer
Research Center; Boukamp et al., 1988). All cell lines, except
WM35, were cultured in DMEM (Invitrogen) supplemented with
10% fetal calf serum (FCS; Biochrom, Berlin, Germany) and 2 mM
glutamine. WM35 cells were propagated in a 4:1 mixture of MCDB
153 medium (with 1.5 g/l sodium bicarbonate) and Leibovitz’s L-15
medium (both from Biochrom), supplemented with 2 mM L-gluta-
mine, 0.005 mg/ml bovine insulin, 1.68 mM CaCl2, and 2% FCS. For
isolation of primary human fibroblasts, human dermis was washed
with phosphate-buffered saline (PBS) and cut into small pieces,
which then were placed on glass coverslips and transferred into
culture flasks containing DMEM plus 10% FCS, 2 mM glutamine, and
100 U/ml penicillin/streptomycin (Invitrogen). Cells were subcul-
tured for the first time afterB2 weeks and were used for experiments
in passage 4. Preparation and cell culture of human umbilical vein
endothelial cells, used as controls for VE-cad immunoblots, was as
reported previously (Peitsch et al., 1999). All cell lines were
maintained at 371C with 5% CO2 and subdivided twice a week.
For two-dimensional melanoma–fibroblast or melanoma–kerati-
nocyte cocultures, cells were trypsinized, counted in a Neubauer
chamber, and seeded on glass coverslips in a 5:1 ratio (fibroblasts:
melanoma cells or HaCaT:melanoma cells, respectively). Cocultures
were maintained for 3–4 days in DMEM plus 10% FCS before
procession for immunofluorescence analysis.
Organotypic cocultures
Organotypic cocultures were prepared essentially as described by
Stark et al. (1999). Dermal equivalents were generated with native
type I collagen extracted from rat-tail tendons. The lyophilized
collagen was redissolved with 0.1% acetic acid (final concentration:
4 mg/ml) and eight volumes of ice-cold collagen solution were mixed
with one volume of 10Hank’s buffered saline, followed by
neutralization with NaOH up to a pH value of 7.0. Fibroblasts were
trypsinized, counted, and resuspended in 100% FCS. One volume of
fibroblast/FCS solution was added, resulting in a final concentration of
3.2 mg/ml collagen and 2 105 cells/ml. Of this mixture, 2.5 ml each
were poured into PET membrane filter inserts (Falcon no. 3090, BD
Biosciences), placed into special deep six-well trays (Biocoat 355464,
BD Biosciences) and allowed to harden for 1 hour at 371C. Glass rings
(24 mm outer, 20 mm inner diameter) were put on the gels to
compress them and to provide a central flat area for keratinocyte
seeding. The gels were equilibrated over night with DMEM
supplemented with 10% FCS and with 50mg/ml ascorbic acid
(Sigma). In total, 1 106 cells were seeded. The next day, HaCaT
keratinocytes (passage 40), mixed with MeWo or C32 melanoma cells
in a 5:1 ratio, were seeded on the top of the collagen matrix using
DMEM with 10% FCS and 50mg/ml ascorbic acid as culture medium,
supplemented, for the first week, with 2 ng/ml epidermal growth
factor (PromoCell) and 2 ng/ml transforming growth factor-a (R&D
Systems, Minneapolis, MN). After submerse incubation over night, the
cultures were raised to the air medium interface by lowering the
medium level. The medium was changed every second day. Cultures
were harvested after 14 days, embedded in Tissue-Tek (Sakura,
Zoeterwoude, The Netherlands) and frozen in liquid nitrogen.
Tissues
Samples of human skin, split skin, and human MM metastases were
obtained in the course of routine pathological diagnoses from the
Departments of Dermatology and Pathology of the Medical Center
Mannheim. Samples were snap-frozen in isopentane, which had
been precooled to 801C in liquid nitrogen and stored at 801C.
Procedures were performed with approval of the medical ethical
committee of the Medical Center Mannheim of the University of
Heidelberg, with patients’ informed consent and according to the
Declaration of Helsinki Principles. For analyses of the cad profiles in
melanoma metastases, immunolabelled cryostat sections were
evaluated by two independent investigators with respect to the
proportion of immunoreactive tumor cells. Metastases with 10–50%
immunoreactive tumor cells were classified as ‘‘þ ’’, those with
50–75% reactive cells as ‘‘þ þ ’’, and those withX75% as ‘‘þ þ þ ’’
(Table 2).
Immunoblotting, IP, and matrix-assisted laser desorption
ionization analyses
Immunoblotting was performed as described by Peitsch et al. (1999),
using total protein lysates of cultured cells or of human skin. For IP,
cells grown to confluency were lysed either in a Triton X-100 IP
buffer, containing 1% Triton X-100, 150 mM NaCl, and 20 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.4) or in a RIPA
buffer composed of 1% Triton X-100, 0.1% SDS, 0.5% sodium
desoxycholate, 1 mM dithiothreitol, 0.5 mM CaCl2, 150 mM NaCl, and
20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.4),
both supplemented with a protease-inhibitor cocktail (Complete
Table 3. Origins of the different melanoma cell
culture lines used in this study
Melanoma cell
line Origin
MeWo Lymph node metastasis
WM-115 Primary melanoma, skin
WM-266-4 Skin metastasis
WM-793 Primary melanoma, skin (SSM, vertical growth phase)
C32 Primary melanoma, skin (amelanotic melanoma)
SK-Mel-2 Skin metastasis
Malme-3M Lung metastasis
WM35 Primary melanoma, skin (SSM, vertical and radial
growth phase)
SSM, superficial spreading melanoma.
All lines were obtained from American Type Culture Collection.
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Mini Inhibitor Tabs, EDTA-free; Roche Diagnostics, Mannheim,
Germany), for 1 hour on ice. The supernatants obtained after
centrifugation at 14.000 r.p.m. for 10 minutes (41C) were subjected
to IP, using pan mouse IgG or sheep anti-rabbit IgG Dynabeads
(Dynal, Hamburg, Germany; cf. Peitsch et al., 1999, 2005). Trypsin
digestion and matrix-assisted laser desorption ionization–time of
flight analyses were conducted by Dr Martina Schno¨lzer and Dr Tore
Kempf (Protein Analysis Facility, German Cancer Research Center),
as previously reported (Peitsch et al., 1999).
RNA isolation, cDNA synthesis, and PCR
Isolation of total RNA from cultured cells and human split skin was
performed with TriPure Isolation Reagent (Roche Diagnostics),
according to the manufacturer’s instructions. Cultured cells were
vigorously vortexed and pipetted up and down for homogenization;
split skin was pulverized in a micro-dismembrator (Braun Biotech
International, Melsungen, Germany). The final concentrations of
RNA were determined in an Ultrospec 2100 pro spectrometer (GE
Healthcare Life Sciences, formerly Amersham Biosciences, Buck-
inghamshire, England), and quality was checked on formaldehyde-
containing 1% agarose gels. For long-term storage at 801C, RNA
was precipitated with 2.5 volumes ethanol and 0.1 volume 3 M
sodium acetate (pH 5.2).
Synthesis of cDNA was conducted with 10mg total RNA as
template, using 0.6 mM dNTP , 0,75mg random primer dT7, 40 U
protector RNAse inhibitor, and 10 U AMV reverse transcriptase in 50ml
1AMV reverse transcriptase buffer (Roche Diagnostics), at 411C for
1 hour, 511C for 30 minutes, and 921C for 3 minutes. The cDNA
samples were replenished to a volume of 1 ml with TE buffer. For PCR,
aliquots of 5ml cDNA were utilized together with 0.2 mM deoxyribo-
nucleotide triphosphate, 100 ng of each oligonucleotide primer and 1 U
TAQ DNA polymerase in 50ml MgCl2-containing PCR buffer (Roche
Diagnostics). The reaction profile was as follows: 3 minutes 941C (initial
denaturation), 34 cycles at 941C (20 seconds), 541C (30 seconds), and
721C (1 minute), followed by a final elongation step at 721C for
10 minutes. PCRs were performed for human Dsg1 (forward primer:
50-GCACTGGTACAATTAATATTAACA-30; reverse primer: 50-TCCC
TGGGTTCAGGCTGTGGTCCT-30), human Dsg2 (forward primer:
50-GCCAAGAAAGTACCAGTGTGCTGC-30; reverse primer: 50-CTTT
CATCGTGGCTTCCTTGGCCA-30) and, for control, for the actin-
binding protein drebrin (forward primer: 50-TTTAGATCTGCCGGCGT
CAGCTTCAGCGGC-30; reverse primer: 50-CGCACTTGCGGGCAT
CAGGCACAT-30). PCR fragments were analyzed on 2% agarose gels.
Immunofluorescence and confocal laser scanning microscopy
For immunostainings, cultured cells grown on glass coverslips were
fixed in 2% formaldehyde for 5–7 minutes, treated with NH4Cl for
blocking of free aldehyde groups (5 minutes), washed in PBS
(5 minutes), and permeabilized with 0.1% Triton-X (2–3 minutes),
followed by two washes in PBS. Alternatively, fixation was
performed for 5 minutes at 201C in methanol and permeabilization
for 20 seconds in acetone (201C). For staining of tissues and
organotypic HaCaT–melanoma cell cultures, frozen samples were
sectioned at 5mm thickness, using a Jung CM3000 cryomicrotome
(Leica Microsystems, Wetzlar, Germany), air-dried for a minimum of
1 hour and either fixed in 2% formaldehyde as described above or in
acetone for 10 minutes at 201C. Before incubation with the first
antibody, sections were blocked with 5% goat serum for 20 minutes.
Both on cultured cells and on cryostat sections, primary antibodies
were applied for 1 hour at room temperature, followed by three
washes in PBS (5 minutes each), incubation with the secondary
antibody (30 minutes, room temperature), washing with PBS
(3 5 minutes), a short rinse in distilled water, and dehydration in
100% ethanol (1 minute). After air-drying, specimens were mounted
with Fluoromount-G (Southern Biotech, obtained through Biozol
Diagnostica, Eching, Germany).
PKPs are dual localization proteins, facultatively accumulating
not only in intercellular contacts but also in the nucleus (Mertens
et al., 1996). The latter localization can best be visualized with a
special short staining method guaranteeing minimal loss of soluble
proteins, which was applied for PKP staining in addition to the
above-mentioned protocols (Schmidt et al., 1999). After methanol/
acetone fixation, cells were incubated with primary antibodies only
for 15 minutes, washed only twice for 2 minutes, covered with the
secondary antibodies for 15 minutes, and washed twice for 2 minutes
before mounting.
Immunofluorescence microscopical images were recorded with
an Axiophot II photomicroscope (Carl Zeiss, Jena, Germany)
equipped with an AxioCam HR (Carl Zeiss), for confocal laser
scanning microscopy a Zeiss LSM 519UV microscope was used.
Electron and immunoelectron microscopy
Electron and immunoelectron microscopy was accomplished
essentially as described (Langbein et al., 2002). Briefly, for
conventional electron microscopy, cells grown on coverslips were
fixed in 2.5% glutaraldehyde in 50 mM sodium cacodylate (pH 7.2)
for 30 minutes and then washed thrice in the same buffer.
Postfixation was performed with 2% OsO4 (cacodylate buffer) for
2 hours, followed first by several washes in distilled water and then
by heavy metal staining (0.5% uranylacetate) overnight at 41C. After
three washes in distilled water, samples were dehydrated through an
ethanol series and in propylenoxide, followed by embedding in
Epon. Ultrathin sections for electron microscopy (EM) were made
with a Reichert-Jung microtome (Utracut, Leica, Bensheim, Ger-
many). For contrast enhancement, the sections were stained with 2%
uranylacetate in methanol for 15 minutes and with lead citrate for
5 minutes.
For immunoelectron microscopy, cells were fixed in 2%
formaldehyde and permeabilized with 0.1% Triton X-100 as
mentioned above. Primary antibodies were applied for 2 hours.
Antibodies conjugated with 1.4-nm gold particles (Nanogold,
Biotrend, Cologne, Germany) were used as secondary reagent and
incubated for 4 hours. Postfixation and silver enhancement were
performed as described (Langbein et al., 2002). Electron micrographs
were taken at 80 kV, using an EM 910 (Carl Zeiss).
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